Montelukast Prescribing at FIRECLAY HEALTH
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
770
Total Quantity
32.7K
NHS Cost
£1.5K
vs National Avg
+12.5%
FIRECLAY HEALTH prescribed 770 items of Montelukast over the last 12 months at a cost of £1,486 to the NHS. This is 12.5% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
59
Jul 2026
65
Jul 2026
76
Jul 2026
54
Jul 2026
57
Jul 2026
67
Jul 2026
65
Jul 2026
60
Jul 2026
81
Jul 2026
55
Jul 2026
62
Jul 2026
69
Prescribing Details
| Total Items | 770 |
|---|---|
| Total Quantity | 32,669 |
| Total NHS Cost | £1,486 |
| Presentations | 4 different forms |
| vs National Average | +12.5% |
Montelukast Prescribing Comparison
| This practice | 770 items |
|---|---|
| National average per practice | 685 items |
| Difference | +12.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.